Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS591726B2 - Method for producing a polymer compound with anticancer properties - Google Patents
[go: Go Back, main page]

JPS591726B2 - Method for producing a polymer compound with anticancer properties - Google Patents

Method for producing a polymer compound with anticancer properties

Info

Publication number
JPS591726B2
JPS591726B2 JP5699082A JP5699082A JPS591726B2 JP S591726 B2 JPS591726 B2 JP S591726B2 JP 5699082 A JP5699082 A JP 5699082A JP 5699082 A JP5699082 A JP 5699082A JP S591726 B2 JPS591726 B2 JP S591726B2
Authority
JP
Japan
Prior art keywords
arabinofuranosylcytosine
polymer compound
water
producing
mol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP5699082A
Other languages
Japanese (ja)
Other versions
JPS58174409A (en
Inventor
隆 平野
敏 森本
圭四郎 津田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institute of Advanced Industrial Science and Technology AIST
Original Assignee
Agency of Industrial Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency of Industrial Science and Technology filed Critical Agency of Industrial Science and Technology
Priority to JP5699082A priority Critical patent/JPS591726B2/en
Publication of JPS58174409A publication Critical patent/JPS58174409A/en
Publication of JPS591726B2 publication Critical patent/JPS591726B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Saccharide Compounds (AREA)

Description

【発明の詳細な説明】 本発明は、長時間にわたつて持続する抗がん性を示す新
規高分子化合物の製造方法に関するものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing a novel polymer compound that exhibits long-lasting anticancer properties.

さらに詳しくいえば、本発明は、式力O ・・・・・・
(I) −゜゜れイ で示されるアラビノフラノシルシトシン残基をもつ水溶
性重合体の製造方法に関するものである。
To be more specific, the present invention provides a formula force O...
(I) This invention relates to a method for producing a water-soluble polymer having an arabinofuranosylcytosine residue represented by -゜゜Re.

アラビノフラノシルシトシンCは白血病に有効な制がん
剤として知られているが、これを投与すると体内で急速
に分解しその効力を失うため、長時間にわたつて効力を
持続させるには、点滴などにより連続的に投与しなけれ
ばならないという不便さがある。他方、医薬の効力を持
続させる手段として、有効成分を適当な重合体に結合し
、これを体内で徐徐に放出させる方法が知られている。
Arabinofuranosylcytosine C is known as an anticancer drug that is effective against leukemia, but when administered, it rapidly degrades in the body and loses its efficacy, so in order to maintain its efficacy over a long period of time, It has the inconvenience of having to be administered continuously through an intravenous drip or the like. On the other hand, as a means for sustaining the efficacy of pharmaceuticals, a method is known in which an active ingredient is bound to a suitable polymer and the polymer is gradually released within the body.

そして、アラビソフラノシルシトシンについても、これ
をカルボキシル基をもつ重合体とカルボジイミドの存在
下で反応させ高分子化する方法が提案されている。
As for arabisofuranosylcytosine, a method has been proposed in which it is made into a polymer by reacting it with a polymer having a carboxyl group in the presence of carbodiimide.

しかし、この方法ではアラビノフラノシルシトシンの導
入率に制限があり、60重量%以上の導入率を得ること
は困難である上に、使用しうる重合体も制限され、治療
に応じて適した重合体を選ぶことができないという欠点
がある。本発明者らは、このような従来のアラビノフラ
ノシルシトシンの持続性誘導体のもつ欠点を克服するた
めに、鋭意研究を重ねた結果、先ずアラビノフラノシル
シトシンの重合性誘導体を製造し、これを単独もしくは
他の共重合しうる単量体と組み合わせて重合させれば、
活性成分の導入率を高めたり、任意に制御しうることを
見出し、この知見に基づいて本発明をなすに至つた。す
なわち、本発明は、一般式 (式中のRは水素原子又はメチル基である)で示される
アラビノフラノシルシトシン誘導体2〜60モル%と、
単独で重合させたときに水溶性重合体を生成する単量体
98〜40モル%とを共重合させることを特徴とする抗
がん性を有する高分子化合物の製造方法を提供するもの
である。
However, this method has limitations on the introduction rate of arabinofuranosylcytosine, making it difficult to achieve an introduction rate of 60% by weight or more, and also limits the types of polymers that can be used. The disadvantage is that the polymer cannot be selected. In order to overcome the drawbacks of such conventional long-lasting derivatives of arabinofuranosylcytosine, the present inventors have conducted extensive research and have first produced a polymerizable derivative of arabinofuranosylcytosine, If this is polymerized alone or in combination with other copolymerizable monomers,
We have discovered that the introduction rate of active ingredients can be increased and controlled as desired, and based on this knowledge, we have accomplished the present invention. That is, the present invention provides 2 to 60 mol% of an arabinofuranosylcytosine derivative represented by the general formula (R in the formula is a hydrogen atom or a methyl group),
Provided is a method for producing a polymeric compound having anticancer properties, characterized by copolymerizing with 98 to 40 mol% of a monomer that produces a water-soluble polymer when polymerized alone. .

本発明方法において用いる一般式()のアラビノフラノ
シルシトシン誘導体は、文献未載の新規化合物であつて
、例えばアクリル酸又はメタクリル酸あるいはそれらの
反応性誘導体とアラビノフラノシルシトシンとを反応さ
せることによつて製造される。また、単独で重合させた
ときに水溶性重合体を生成する単量体としては、例えば
N−ビニルピロリドン、2−ビニルピリジン−N−オキ
シド、2−(メチルスルフイニル)エチルメタクリレー
ト、2−(メチルスルフイニル)エチルアクリレート、
アクリルアミド、ヒドロキシルエチルメタクリレート及
びヒドロキシルエチルアクリレートの中から選ばれた少
なくとも1種が用いられる。
The arabinofuranosylcytosine derivative of the general formula () used in the method of the present invention is a novel compound that has not been described in any literature, and is obtained by reacting, for example, acrylic acid or methacrylic acid or a reactive derivative thereof with arabinofuranosylcytosine. Manufactured by Examples of monomers that produce water-soluble polymers when polymerized alone include N-vinylpyrrolidone, 2-vinylpyridine-N-oxide, 2-(methylsulfinyl)ethyl methacrylate, 2- (methylsulfinyl)ethyl acrylate,
At least one selected from acrylamide, hydroxylethyl methacrylate, and hydroxylethyl acrylate is used.

前記一般式()のアラビノフラノシルシトシン誘導体は
、単量体全量の2〜60モル%の割合で使用される。
The arabinofuranosylcytosine derivative of the general formula () is used in an amount of 2 to 60 mol% of the total amount of monomers.

この量が2モル%未満では抗がん作用力坏十分になるし
、また60モル%よりも多くなると十分な持続性が発揮
されなくなる。本発明方法を好適に実施するには、前記
一般式()のアラビノフラノシルシトシン誘導体と単独
で重合させたときに水溶性重合体を生成する単量体との
所定割合を、溶媒例えば水、アルコール類に20〜70
%の濃度で溶解し、重合開始剤を加えて加熱しながら反
応させる。
If this amount is less than 2 mol%, the anticancer effect will not be sufficient, and if it is more than 60 mol%, sufficient sustainability will not be exhibited. In order to suitably carry out the method of the present invention, a predetermined proportion of the arabinofuranosylcytosine derivative of the general formula () and the monomer that produces a water-soluble polymer when polymerized alone is mixed with a solvent such as water. , 20-70 for alcohol
% concentration, add a polymerization initiator, and react while heating.

この際、反応は不活性雰囲気例えばアルゴン、ヘリウム
、窒素などの雰囲気中で行うのが有利である。重合開始
剤としては、過酢酸、過酸化ベンゾイル、過硫酸塩のよ
うな過酸化物、アゾビスイソブチロニトリル、レドツク
ス触媒などラジカル重合に慣用されているものが用いら
れる。反応温度としては40〜100℃の範囲の温度が
用いられ、反応時間は、使用される単量体、重合開始剤
や反応温度により変わるが、通常30分ないし10時間
の範囲である。反応終了後、反応混合物から再沈殿法な
どにより生成物を分離し、精製したのち、水溶液から凍
結乾燥すれば目的の高分子化合物が白色綿状物質として
得られる。この高分子化合物は、約1〜10万の範囲の
平均分子量を有する水溶性の物質である。この高分子化
合物は、水中で徐々にアラビノフラノシルシトシンCを
放出する性質を有するので、長時間持続性制がん剤とし
て好適である。次に参考例、実施例により本発明をさら
に詳細に説明する。参考例 1 水20m1中にアラビノフラノシルシトシンC2.2t
を溶解し、さらにジオキサン6077!11を加える。
In this case, it is advantageous to carry out the reaction in an inert atmosphere, such as argon, helium, nitrogen or the like. As the polymerization initiator, those commonly used in radical polymerization such as peroxides such as peracetic acid, benzoyl peroxide, and persulfates, azobisisobutyronitrile, and redox catalysts are used. The reaction temperature used is in the range of 40 to 100°C, and the reaction time varies depending on the monomers used, the polymerization initiator, and the reaction temperature, but is usually in the range of 30 minutes to 10 hours. After the reaction is completed, the product is separated from the reaction mixture by a reprecipitation method, purified, and then freeze-dried from the aqueous solution to obtain the desired polymer compound as a white flocculent material. This polymer compound is a water-soluble substance having an average molecular weight in the range of about 10,000 to 100,000. Since this polymer compound has the property of gradually releasing arabinofuranosylcytosine C in water, it is suitable as a long-lasting anticancer agent. Next, the present invention will be explained in more detail with reference to Reference Examples and Examples. Reference example 1 2.2t of arabinofuranosylcytosine C in 20ml of water
Dissolve and further add dioxane 6077!11.

次にこの混合物中へ無水メタクリル酸2.8fを加え、
室温下、48時間かきまぜ、反応を完了させる。次いで
反応混合物を室温下で減圧濃縮後、濃縮液をn−ヘキサ
ン中に滴下し、析出した沈殿をろ別する。この沈殿を水
100meに溶解し、陽イオン交換樹脂を通して不純分
を除いたのち、通過液を凍結乾燥する。残留物をメタノ
ールとエーテルの混合液から再結晶することにより、N
−メタクリロイル一1,β,D−アラビノフラノシルシ
トシンが融点144〜146℃の白色針状結晶として得
られる。参考例 2 無水メタクリル酸2.87の代りに無水アクリル酸2.
37を用い、参考例1と全く同様に操作し、融点121
〜123℃の白色針状結晶として、N−アクリロイル−
1,β,D−アラビノフラノシルシトシンを得た。
Next, 2.8f of methacrylic anhydride was added to this mixture,
Stir at room temperature for 48 hours to complete the reaction. Next, the reaction mixture was concentrated under reduced pressure at room temperature, and the concentrated solution was added dropwise into n-hexane, and the precipitate deposited was filtered off. This precipitate is dissolved in 100 ml of water, passed through a cation exchange resin to remove impurities, and the resulting solution is freeze-dried. By recrystallizing the residue from a mixture of methanol and ether, N
-Methacryloyl-1,β,D-arabinofuranosylcytosine is obtained as white needle-like crystals with a melting point of 144-146°C. Reference example 2 Acrylic anhydride instead of methacrylic anhydride 2.87.
No. 37 was used and operated in exactly the same manner as in Reference Example 1, and the melting point was 121.
N-acryloyl- as white needle-like crystals at ~123°C
1,β,D-arabinofuranosylcytosine was obtained.

実施例 1 参考例1で得たN−メタクリロイル一1,β,D−アラ
ビノフラノシルシトシン13.47とNビニルピロリド
ン6.37とを水50?中に溶解し、過硫酸アンモニウ
ム0.17を加え、アルゴン雰囲気中において70℃で
5時間反応させた。
Example 1 13.47% of N-methacryloyl-1,β,D-arabinofuranosylcytosine obtained in Reference Example 1 and 6.37% of N-vinylpyrrolidone were mixed with 50% of water. 0.17 ammonium persulfate was added thereto, and the mixture was reacted at 70° C. for 5 hours in an argon atmosphere.

反応混合物を濃縮し、濃縮物をエタノール中に注加し、
生成した沈殿をろ取し、さらに水への溶解、エタノール
からの再沈殿を繰り返して精製したのち、水中より凍結
乾燥することにより、アラビノフラノシルシトシンC含
量約43重量%の共重合体を白色綿状物として得た。こ
のものの30℃における極限粘度は0.16であり、光
散乱法により求めた平均分子量は約16000であつた
Concentrate the reaction mixture, pour the concentrate into ethanol,
The generated precipitate was collected by filtration, further purified by repeating dissolution in water and reprecipitation from ethanol, and then lyophilized from water to obtain a copolymer with an arabinofuranosylcytosine C content of approximately 43% by weight. Obtained as a white floc. The intrinsic viscosity of this product at 30° C. was 0.16, and the average molecular weight determined by a light scattering method was about 16,000.

このものの他の物性は次のとおりである。元素分析値: 紫外線吸収スペクトル:305,250nmに極大溶解
性: 可溶 水(1.2t/Me)、ジメチルスルホキ
シド不溶 エタノール また、このものの赤外線吸収スペクトルを第1図に示す
Other physical properties of this product are as follows. Elemental analysis values: Ultraviolet absorption spectrum: Maximum solubility at 305, 250 nm: Soluble Water (1.2t/Me), Dimethyl sulfoxide Insoluble Ethanol Also, the infrared absorption spectrum of this product is shown in FIG.

実施例 2 参考例2で得たN−アクリロイル−1,β,Dーアラビ
ノフラノシルシトシンとN−ビニルピロリドンとの等モ
ル混合物を用い、実施例1と同様に重合させることによ
り、アラビノフラノシルシトシンC含量約50モル%の
共重合体を得た。
Example 2 Using an equimolar mixture of N-acryloyl-1,β,D-arabinofuranosylcytosine obtained in Reference Example 2 and N-vinylpyrrolidone, arabino- A copolymer having a furanosylcytosine C content of about 50 mol% was obtained.

このものの平均分子量は約25000であつた。参考例
3実施例1で得た共重合体27を、PH7。
The average molecular weight of this product was about 25,000. Reference Example 3 Copolymer 27 obtained in Example 1 was adjusted to pH 7.

2の0.01M−リン酸緩衝液100d中に溶かし、3
7℃におけるそのアラビノフラノシルシトシンCの放出
速度を、紫外線吸収スペクトルの305nmの極大点の
減少率から求めた。
2 in 100 d of 0.01M phosphate buffer,
The release rate of arabinofuranosylcytosine C at 7°C was determined from the rate of decrease of the maximum point at 305 nm in the ultraviolet absorption spectrum.

その結果をグラフとして第2図に示す。このグラフから
明らかなように1日当り2%の割合でアラビノフラノシ
ルシトシンCが放出され、これが2週間以上継続する。
The results are shown in FIG. 2 as a graph. As is clear from this graph, arabinofuranosylcytosine C is released at a rate of 2% per day, and this continues for more than two weeks.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は本発明により得られた高分子化合物の赤外線吸
収スペクトル図、第2図はその高分子化合物についての
活性成分の放出速度を示すグラフである。
FIG. 1 is an infrared absorption spectrum diagram of the polymer compound obtained according to the present invention, and FIG. 2 is a graph showing the release rate of the active ingredient for the polymer compound.

Claims (1)

【特許請求の範囲】 1 一般式 ▲数式、化学式、表等があります▼ (式中のRは水素原子又はメチル基である)で示される
アラビノフラノシルシトシン誘導体2〜60モル%と、
単独で重合させたときに水溶性重合体を生成する単量体
98〜40モル%とを共重合させることを特徴とする抗
がん性を有する高分子化合物の製造方法。 2 単独で重合させたときに水溶性重合体を生成する単
量体が、N−ビニルピロリドン、2−ビニルピリジン−
N−オキシド、2−(メチルスルフィニル)エチルメタ
クリレート、2−(メチルスルフィニル)エチルアクリ
レート、アクリルアミド、ヒドロキシルエチルメタクリ
レート及びヒドロキシルエチルアクリレートの中から選
ばれた少なくとも1種である特許請求の範囲第1項記載
の方法。
[Claims] 1 2 to 60 mol% of an arabinofuranosylcytosine derivative represented by the general formula ▲ Numerical formula, chemical formula, table, etc. ▼ (R in the formula is a hydrogen atom or a methyl group);
A method for producing a polymer compound having anticancer properties, which comprises copolymerizing a monomer with 98 to 40 mol% of a monomer that produces a water-soluble polymer when polymerized alone. 2 Monomers that produce water-soluble polymers when polymerized alone are N-vinylpyrrolidone, 2-vinylpyridine-
Claim 1 is at least one selected from N-oxide, 2-(methylsulfinyl)ethyl methacrylate, 2-(methylsulfinyl)ethyl acrylate, acrylamide, hydroxylethyl methacrylate, and hydroxylethyl acrylate. the method of.
JP5699082A 1982-04-06 1982-04-06 Method for producing a polymer compound with anticancer properties Expired JPS591726B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5699082A JPS591726B2 (en) 1982-04-06 1982-04-06 Method for producing a polymer compound with anticancer properties

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5699082A JPS591726B2 (en) 1982-04-06 1982-04-06 Method for producing a polymer compound with anticancer properties

Publications (2)

Publication Number Publication Date
JPS58174409A JPS58174409A (en) 1983-10-13
JPS591726B2 true JPS591726B2 (en) 1984-01-13

Family

ID=13042927

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5699082A Expired JPS591726B2 (en) 1982-04-06 1982-04-06 Method for producing a polymer compound with anticancer properties

Country Status (1)

Country Link
JP (1) JPS591726B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0516588U (en) * 1991-08-14 1993-03-02 日本ソリツド株式会社 Collision prevention material with alarm

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2686936B2 (en) * 1987-10-27 1997-12-08 日本油脂株式会社 Macrophage activator encapsulated in liposomes

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0516588U (en) * 1991-08-14 1993-03-02 日本ソリツド株式会社 Collision prevention material with alarm

Also Published As

Publication number Publication date
JPS58174409A (en) 1983-10-13

Similar Documents

Publication Publication Date Title
Roy et al. Sugar-responsive block copolymers by direct RAFT polymerization of unprotected boronic acid monomers
CA1309657C (en) Biodegradable microspheres as a carrier for macromolecules
EP0263605B1 (en) Wound dressing
JPH07330618A (en) Vascular embolic agent
JP2008239997A (en) Zwitterionic polymer
US4889530A (en) Wound dressing containing acrylate or methacrylate hydrogel polymer
JPWO1992014365A1 (en) antibacterial agents
CN114656603B (en) Preparation method of branched structure water-soluble polymer
US4097470A (en) Preparation of biogically active substances bearing -NH2 groups in a form releasable by enzymatic cleavage
Smets et al. Graft copolymerization with perester side groups
US3969329A (en) Process for producing high molecular weight acrylamide water-soluble polymers by controlling the viscosity of the polymerization reaction medium with a water-miscible organic solvent
JPS591726B2 (en) Method for producing a polymer compound with anticancer properties
US6100338A (en) Fine grain carriers and medicinal composition prepared with the use of the same
WO1992007884A1 (en) Organic polymer compound and production thereof
JPH0555523B2 (en)
JPH0258279B2 (en)
Ouchi et al. Vinyl polymerization. 410. Polymerizations of vinyl monomers initiated by poly (styrene‐co‐sodium acrylate) or poly (methyl methacrylate‐co‐sodium methacrylate). A verification of the concept of hard and soft hydrophobic areas and monomers
JP2001048938A (en) New polymer and its use
JP3664822B2 (en) Particulate carrier
JP3558354B2 (en) Thermoreversible polymer compound and method for producing the same
CN116023577B (en) An amphiphilic copper-containing polymer nanoparticle and its preparation and application
JP3200942B2 (en) Boronic acid group-containing monomer and polymer thereof
JPH0569846B2 (en)
JPS5813609A (en) Preparation of crosslinked ampholytic polymer
Yamada et al. Contribution of primary radical termination to radical polymerization of diethyl fumarate estimated from absolute rate constants